# US 2022/0015437 A1 · E-cigarette

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2022/0015437 A1
- Document ID: US20220015437A1
- Status: Published application
- Kind: A1
- Application number: 17/295,502
- Filed: 2019-11-18
- Published: 2022-01-20
- Earliest claimed: 2018-11-22
- Assignees: Smokeless.World GmbH
- Applicants: Smokeless.World GmbH
- Inventors: Daniel KILGER; Michael SEDLMEIER; Patrick MÜLLER
- Web page: https://patentgrep.com/patent/US20220015437A1

## CPC

- A24F 40/50: Control or monitoring
- A24F 40/10: Devices using liquid inhalable precursors
- A24F 40/30: Devices using two or more structurally separated inhalable precursors, e.g. using two liquid precursors in two cartridges
- A24F 40/42: Cartridges or containers for inhalable precursors
- A24F 40/53: Monitoring, e.g. fault detection
- A24F 40/65: Devices with integrated communication means, e.g. wireless communication means
- A61M 11/042: {electrical}
- A61M 15/0003: {with means for dispensing more than one drug}
- A61M 15/0066: {with means for varying the dose size}
- A63F 13/245: specially adapted to a particular type of game, e.g. steering wheels
- G16H 20/13: delivered from dispensers
- A61M 11/005: {using ultrasonics (spraying or atomising liquids using ultrasonic vibrations in general B05B17/06)}
- A61M 15/0085: {using ultrasonics (spraying or atomising liquids using ultrasonic vibrations in general B05B17/06)}
- A61M 15/06: Inhaling appliances shaped like cigars, cigarettes or pipes
- A61M 2205/13: with means for the detection of operative contact with patient, e.g. lip sensor
- A61M 2205/332: Force measuring means
- A61M 2205/3553: remote, e.g. between patient's home and doctor's office
- A61M 2205/3569: sublocal, e.g. between console and disposable
- A61M 2205/3592: using telemetric means, e.g. radio or optical transmission
- A61M 2205/505: Touch-screens; Virtual keyboard or keypads; Virtual buttons; Soft keys; Mouse touches
- A61M 2205/52: with memories providing a history of measured variating parameters of apparatus or patient
- A61M 2205/584: having a color code
- A61M 2205/609: Biometric patient identification means
- A61M 2205/8206: battery-operated
- A24F: SMOKERS' REQUISITES; MATCH BOXES; SIMULATED SMOKING DEVICES (inhaling appliances for medical purposes, shaped like cigars, cigarettes or pipes A61M15/06)
- A61M: DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY (introducing media into or onto the bodies of animals A61D7/00; means for inserting tampons A61F13/26; devices for administering food or medicines orally A61J; containers for collecting, storing or administering blood or medical fluids A61J1/05); DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY (surgery A61B; chemical aspects of surgical articles A61L); DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR {(Electrotherapy, e.g. producing anaesthesia by the use of alternating or intermittent currents A61N1/36021)}
- A63F: CARD, BOARD, OR ROULETTE GAMES; INDOOR GAMES USING SMALL MOVING PLAYING BODIES; VIDEO GAMES; GAMES NOT OTHERWISE PROVIDED FOR
- G16H: HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA

## Abstract

The present invention is directed to a system for dosing an inhaling composition. It is preferably integrated into an e-cigarette. The system comprises more than one component for the inhaling composition. A first container (30) can be provided for a first component for the composition. A second container (31) can be further provided for a second component for the composition. Moreover, a dosing arrangement (10, 11, 40) can be arranged that is configured to automatically reduce the dose of at least the second component over time.

## Claims

### Claim at position 1

1-18. (canceled)

### Claim 19

A system for dosing an inhaling composition, the system comprising:
a. a first container for a first component of the composition;
b. a second container for a second component of the composition; and
c. a dosing arrangement that is configured to dose at least the second component in time intervals of at most 200 ms;
wherein
d. the dosing arrangement is configured to automatically reduce the dose of at least the second component over time; and
e. the system is a mobile device, preferably a battery driven mobile device and more preferably an electronic cigarette or e-cigarette.

### Claim 20 (depends on 19)

The system according to claim 19 wherein the dosing arrangement is configured to reduce a number of inhales comprising the second component, preferably by a reduction model, and/or
wherein the dosing arrangement is configured to reduce at least one of an amount of the second component over a number of inhales and a number of doses of the second component during an inhale.

### Claim 21 (depends on 19)

The system according to claim 19, wherein
a. the dosing arrangement comprises
i. a first aerosol generator that is configured to vaporize the first component to a first aerosol, preferably so as to provide a first aerosol as a carrier component together with air; and
ii. a second aerosol generator that is configured to vaporize the second component to a second aerosol; and/or
iii. a data storage; and wherein
b. the system comprises a controller that is configured to control at least one of the first and second aerosol generators.

### Claim 22 (depends on 19)

The system according to claim 19, further comprising a boosting member that is configured to overrule the dosing component by a user when activated to change the amount of the second component, particularly to increase the amount of the second component instantly.

### Claim 23 (depends on 19)

The system according claim 19, wherein the dosing component is configured to dose at least the second component in time intervals of at most 100 ms, preferably at most 50 ms, more preferably at most 35 ms, preferably at most 25 ms, more preferably at most 20 ms, more preferably at most 15 ms, even more preferably at most 10 ms and most preferably at most 7, and/or in time intervals of at least 1 ms, preferably at least 2 ms, preferably at least 3 ms, more preferably at least 4 ms, even more preferably at least 5 ms, even more preferably at least 6 ms.

### Claim 24 (depends on 19)

An assembly comprising the system according to claim 19 and further comprising at least one of a handheld device and a remote server wherein the system is configured to communicate with at least one of the handheld device and the remote server.

### Claim 25 (depends on 24)

The assembly according to claim 24 further comprising a software application that is installed on the handheld device that is configured to introduce personalized data of an individual user, such as at least one of age, gender, weight, location, working profiles, smoking habits, number of boost activations per time, and that is making this personalized data available for the training of the reduction model.

### Claim 26 (depends on 25)

The assembly according to claim 25 wherein at least one of the personalized data and the user behavior data is taken as a basis for modifying the reduction model for all users.

### Claim 27 (depends on 26)

The assembly according claim 26 wherein at least one of the personalized data and the user behavior data is taken as a basis for modifying the reduction model for an individual user.

### Claim 28 (depends on 27)

The assembly according to claim 27 wherein the system is configured to be controlled by a remote controller that is preferably configured to control the dosing arrangement, particularly the dosage of the second component to be delivered.

### Claim 29 (depends on 27)

The assembly according to claim 27 wherein the remote controller is configured to control by at least one encrypted command and at least one of the system and the handheld device are configured to decrypt the command and to provide the command to the controller of the system for controlling the dosing arrangement.

### Claim 30

A method for dosing a composition of an inhaling substance in an inhaler, the composition consisting of at least two components, the method comprising the steps of:
a. providing a first component of the composition of the inhaling substance during inhaling;
b. providing a second component of the composition of the inhaling substance during inhaling;
c. wherein at least the second component is dosed in intervals of at most 50 ms during inhaling.

### Claim 31

A method for dosing a composition of an inhaling substance in an inhaler, the composition consisting of at least two components, the method comprising the steps of:
a. providing a first component of the composition of the inhaling substance;
b. providing a second component of the composition of the inhaling substance;
c. detecting a number of inhales;
d. wherein at least the second component is automatically reduced over time.

### Claim 32

A method comprising
a. providing a first component of the composition of the inhaling substance;
b. providing a second component of the composition of the inhaling substance;
c. detecting a number of inhales;
d. wherein at least the second component is automatically reduced over time;
wherein an overruling controlling is configured for activation by a user to change the amount of the second component, particularly to increase the amount of the second component instantly, and wherein at least the second component is dosed in intervals of at most 50 ms during inhaling.

### Claim 33 (depends on 30)

The method according to claim 30, wherein
a. the second component is being controlled by a reduction model wherein a control is controlling the delivery of the second component by the reduction model;
b. user behavior data is collected and taken as a basis for modifying the reduction model;
c. the inhaler is associated with a software application that is installed on a smart handheld device that is configured to introduce personalized data of an individual user, such as at least one of age, gender, weight, location, working profiles, smoking habits and that is making this personalized data available for the training of the reduction model; and
d. data is collected from a plurality of uses or users and computed remotely.
